Bitget Opens TradFi Trading to All Users After Record-Breaking Beta Demand GlobeNewswire January 07, 2026 VICTORIA, Seychelles, Jan. 07, 2026 (GLOBE NEWSWIRE) — Bitget, the world's largest Universal Exchange (UEX), has officially opened its TradFi trading suite to all users, following a private beta that drew overwhelming interest and delivered standout trading activity across gold, […]
Vancouver, British Columbia–(Newsfile Corp. – January 7, 2026) – Provenance Gold Corp. (CSE: PAU) (OTCQB: PVGDF) (“Provenance” or the “Company”) is pleased to announce assay results from the final seven reverse circulation (RC) drill holes in the Tyee and Striker areas which form part of Eldorado West Project in Eastern Oregon. The five new holes
VICTORIA, Seychelles, Jan. 07, 2026 (GLOBE NEWSWIRE) — MEXC, the world's fastest-growing digital asset exchange and a pioneer of true zero-fee trading, announced the launch of Spot DCA, a smarter way to execute dollar-cost averaging strategies. MEXC is committed to providing a user-friendly trading experience, and this feature removes the complexities of market timing, enabling
DUBAI, United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project focused on decentralized lending, has shared updates on its product development as its reported holder count continues to rise. The team has described ongoing work on its lending and borrowing protocol, including a testnet deployment path, core protocol
TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Annual Greater Toronto Area (GTA) home sales declined in 2025 compared to 2024, as economic uncertainty weighed on consumer confidence. Over the same period, listing inventory remained elevated, allowing for selling prices to be negotiated downward, helping improve affordability. “The GTA housing market became more affordable in 2025
Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step down and will continue to work with the Company at a Board level LIfT BioSciences is currently advancing its first IMAN-based product and preparing to initiate a first-in-human Phase 1 clinical trial. This groundbreaking
Collaboration with Amgen to advance a cancer target discovered using DISCO's proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a target that was mapped on the surface of a cancer cell by DISCO's proprietary platform. Under
Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic's Cell-Seq platform for the discovery of novel therapeutic targets. “This collaboration with Ono Pharmaceutical represents another strong validation of our
LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies GlobeNewswire January 07, 2026 Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step down and will continue to work with the Company at a Board level LIfT BioSciences is
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical GlobeNewswire January 07, 2026 Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic's Cell-Seq platform for the discovery of